BeiGene (BGNE) Appoints Shalini Sharp to its Board

Go back to BeiGene (BGNE) Appoints Shalini Sharp to its Board

Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors

September 26, 2024 6:00 AM EDT

SAN MATEO, Calif.--(BUSINESS WIRE)-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Shalini Sharp to its Board of Directors and as a member of the Boards Audit Committee, effective September 27, 2024.

We are fortunate to welcome Shalini to the Board of Directors at this pivotal moment of... More